Oral dabigatran etexilate vs. subcutaneous enoxaparin for the prevention of venous thromboembolism after total knee replacement: the RE‐MODEL randomized trial

Authors: Bengt I. Eriksson, O.E. Dahl, Nadia Rosencher, Andreas Kurth, C. Niek van Dijk, Simon P. Frostick, Peter Kälebo, Anita Vedel Christiansen, Stefan Hantel, Rohan Hettiarachchi, Janet Schnee, Harry R. Büller - Journal of Thrombosis and Haemostasis 2007 cited by 984